<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/CE562D3D-45D5-45B3-99FF-A81611187A1C"><gtr:id>CE562D3D-45D5-45B3-99FF-A81611187A1C</gtr:id><gtr:name>Veterinary Services</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5E9E5F30-A127-4243-AB12-B19B7A50D0E7"><gtr:id>5E9E5F30-A127-4243-AB12-B19B7A50D0E7</gtr:id><gtr:name>Unlisted</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4D8C3EF0-2A9D-4001-81E2-F0A7AAA54256"><gtr:id>4D8C3EF0-2A9D-4001-81E2-F0A7AAA54256</gtr:id><gtr:name>Imagen Biotech</gtr:name><gtr:address><gtr:postCode>M13 9XX</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:department>Dentistry</gtr:department><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/CE562D3D-45D5-45B3-99FF-A81611187A1C"><gtr:id>CE562D3D-45D5-45B3-99FF-A81611187A1C</gtr:id><gtr:name>Veterinary Services</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5E9E5F30-A127-4243-AB12-B19B7A50D0E7"><gtr:id>5E9E5F30-A127-4243-AB12-B19B7A50D0E7</gtr:id><gtr:name>Unlisted</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4D8C3EF0-2A9D-4001-81E2-F0A7AAA54256"><gtr:id>4D8C3EF0-2A9D-4001-81E2-F0A7AAA54256</gtr:id><gtr:name>Imagen Biotech</gtr:name><gtr:address><gtr:postCode>M13 9XX</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/7253385E-9A1C-49F5-A161-EE733F381419"><gtr:id>7253385E-9A1C-49F5-A161-EE733F381419</gtr:id><gtr:firstName>Lisa</gtr:firstName><gtr:surname>Mohamet</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/FF3C4FB8-106D-4AC1-A06A-40C3D375EE86"><gtr:id>FF3C4FB8-106D-4AC1-A06A-40C3D375EE86</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>Michael</gtr:otherNames><gtr:surname>Ward</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=BB%2FK020277%2F1"><gtr:id>AC6D3F65-2EBE-4C11-AF71-F5D82277F157</gtr:id><gtr:title>Manufacturing of iPS cell derived neurons from patients with familial Alzhiemer's disease for drug discovery and stratified medicine applications</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/K020277/1</gtr:grantReference><gtr:abstractText>Progress in understanding many diseases has been hindered by a lack of suitable in vitro models, particularly for diseases in which affected cell types are difficult to access or obtain. Induced pluripotent stem cells (iPSCs) are an ideal alternative source as they can be derived from patients' skin cells and have the potential to form any cell type in the body. However, current technologies are hindered by the inability to reliably produce mature cell types. We have developed a method that enables iPSCs to be reliably differentiated at low cost and high purity into neurons. This offers the ability to utilise these cells for understanding Alzheimer's disease (AD) in the petri dish and developing new treatments and diagnostics for such patients. Ultimately, we aim to produce a technology capable of diagnosing AD and informing treatment options for patients as well as providing industry with the ability to screen and develop novel drugs for this incurable disease.</gtr:abstractText><gtr:fund><gtr:end>2015-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>170769</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Reading</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy Reading</gtr:department><gtr:description>Prof Ben Whalley</gtr:description><gtr:id>EBEB6510-E058-4486-96B7-8A2B29564E26</gtr:id><gtr:impact>Manuscript currently being written</gtr:impact><gtr:partnerContribution>Confidential</gtr:partnerContribution><gtr:piContribution>Confidential</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imagen Biotech</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Imagen-biotech</gtr:description><gtr:id>87C2A155-BABE-4748-AF36-A76A92DC603F</gtr:id><gtr:impact>Technology still in development</gtr:impact><gtr:partnerContribution>Development of an Alzheimer's disease drug screening platform</gtr:partnerContribution><gtr:piContribution>Provision of iPS cells derived from Alzheimer's disease patients for use in drug screening applications.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Sciences Division</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Dr Richard Wade-Martins</gtr:description><gtr:id>CECCC2AA-10CB-4087-AAA7-01DBCC569764</gtr:id><gtr:impact>Manuscript in preparation</gtr:impact><gtr:partnerContribution>Confidential</gtr:partnerContribution><gtr:piContribution>Confidential</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>TSB Stratified Medicine strategy on neurodegenerative diseases workshop. October 2013</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2BFC419B-B9E9-426A-8C2C-554A9B110572</gtr:id><gtr:impact>Discussion/workshop on TSB Stratified Medicine strategy on neurodegenerative diseases

Recommendations made</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>95E86DF9-7F26-495A-8580-186E4162C60D</gtr:id><gtr:impact>MSCA Annual Scientific Meeting, 8th December 2015, Sheffield University, UK.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited lecture: Stem Cells in Drug Discovery conference, 2-3 June 2015, Cambridge University, UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6250CC75-A63E-4FE3-A2F8-F6F659CB3D0C</gtr:id><gtr:impact>Stem Cells in Drug Discovery conference, 2-3 June 2015, Cambridge University, UK</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited research talk. Uppsala University, Sweden. 13th May 2015.</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>43DC3A63-5917-482E-B38C-ED51DF3DE0E1</gtr:id><gtr:impact>Invited research talk. Uppsala University, Sweden. 13th May 2015.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>57000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Proximity to Discovery Secondment Grant</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:id>72BFCC9D-4467-43F0-AFF9-FE0A03427E90</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6091000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>DPUK: Integrated Dementia Research Environment</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>28918645-81E7-48A2-AE2F-933328893BC9</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>81956</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Crack-It UnTangle NC3Rs</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs)</gtr:fundingOrg><gtr:fundingRef>35529-259127</gtr:fundingRef><gtr:id>FFF44B69-658D-4620-9617-F181E525E6D3</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2013-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2329271</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Medical Research Foundation</gtr:department><gtr:description>UK UKDP: Integrated Dementia Research Environment</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M009076/1</gtr:fundingRef><gtr:id>7C650A72-9974-45EB-94F3-D79EF1F47073</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>62537</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IAA Concept study</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>4AC4257E-33E8-4ED0-AEA2-23BC705E3867</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Method for the derivation of neural stem cells from human pluripotent stem cells.</gtr:description><gtr:id>C581A01A-0078-4987-A2B4-ECA854DC1CFC</gtr:id><gtr:impact>Non-exclusive research licence awarded to Imagen-Biotech Ltd</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:patentId>WO2014072720</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>A novel method for the derivation of neural stem cells from human pluripotent stem cells</gtr:title><gtr:yearProtectionGranted>2013</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>TSB Stratified Medicine strategy on neurodegenerative diseases workshop October 2013</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2E48F685-84CC-401C-A2A5-C37525E2CDB5</gtr:id><gtr:impact>Call for neurodegenerative diseases funded</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Alzheimer's disease diagnostic</gtr:description><gtr:id>ECA9CBD4-0F42-44D4-B215-163835104829</gtr:id><gtr:impact>None</gtr:impact><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Alzheimer's disease diagnostic</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Microarray analysis of E-cadherin inhibition in mouse and human ES cells and mammary epithelial tumour cells has been analysed</gtr:description><gtr:id>E378BAB8-6AC6-4C27-BCE0-7836C5F854A3</gtr:id><gtr:impact>Evidence that E-cadherin plays a major part in regulating signalling pathways, proliferation and apoptosis in ES and tumour cells</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Microarray analysis of E-cadherin inhibition in cells</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Small peptides developed during this grant has been used to derive homogeneous populations of neural progenitor cells from iPSCs (human and mouse).</gtr:description><gtr:id>44EE3B90-2819-4FE6-9B78-7945DE9B1056</gtr:id><gtr:impact>NC3Rs Phase 1 grant award for the development of a Tau cell model</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Differentiation of iPSCs to neural progenitor cells</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Small peptides have been developed during this grant that enable modification of gene transcript expression in embryonic stem cells</gtr:description><gtr:id>C4EE2A95-34BF-47D1-B4FB-4E3FE65F66C6</gtr:id><gtr:impact>Several papers published by me and collaborators published</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Peptide development</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>StrataStem Ltd</gtr:companyName><gtr:description>Biotech Start-up</gtr:description><gtr:id>18113F31-D9FA-4F03-87EC-48FB49CDF5B3</gtr:id><gtr:impact>Biotech Start-up</gtr:impact><gtr:yearCompanyFormed>2012</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D5FFCE85-6E01-4D2A-9E49-25EED3E27704"><gtr:id>D5FFCE85-6E01-4D2A-9E49-25EED3E27704</gtr:id><gtr:title>Novel peptides for deciphering structural and signalling functions of E-cadherin in mouse embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/257b181f27a114315e1f5314c7c8d6ee"><gtr:id>257b181f27a114315e1f5314c7c8d6ee</gtr:id><gtr:otherNames>Segal JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/69B9AE14-9458-46A6-AF0A-37B592C0EE1A"><gtr:id>69B9AE14-9458-46A6-AF0A-37B592C0EE1A</gtr:id><gtr:title>High throughput cryopreservation of cells by rapid freezing of sub-?l drops using inkjet printing--cryoprinting.</gtr:title><gtr:parentPublicationTitle>Lab on a chip</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ee1e37719dbf74d7391c6b36e5a96289"><gtr:id>ee1e37719dbf74d7391c6b36e5a96289</gtr:id><gtr:otherNames>Dou R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1473-0189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/14BCB73D-3D05-4384-83B5-6296B66ACE21"><gtr:id>14BCB73D-3D05-4384-83B5-6296B66ACE21</gtr:id><gtr:title>Novel cell lines isolated from mouse embryonic stem cells exhibiting de novo methylation of the E-cadherin promoter.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c64929b77237ad6dcfa3dadf2b85a4e6"><gtr:id>c64929b77237ad6dcfa3dadf2b85a4e6</gtr:id><gtr:otherNames>Hawkins K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C0F22781-AAFE-47C6-828D-34B2FEFCA081"><gtr:id>C0F22781-AAFE-47C6-828D-34B2FEFCA081</gtr:id><gtr:title>Familial Alzheimer's disease modelling using induced pluripotent stem cell technology.</gtr:title><gtr:parentPublicationTitle>World journal of stem cells</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f8b3542ab0bf3972e2cf67bb103b0577"><gtr:id>f8b3542ab0bf3972e2cf67bb103b0577</gtr:id><gtr:otherNames>Mohamet L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1948-0210</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/K020277/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>